GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
      • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
Home / Profiles / José Pedro Gil

José Pedro Gil

Invited Researcher

GHTM Group: Individual Health Care

ProfileResearchLast 5 Publications

José Pedro Gil holds a MSc in Medicine from the University of Aberdeen, UK and a PhD from NOVA School of Science and Technology, Portugal. In 2022, he is joining the Global Health and Tropical Medicine Research Centre (GHTM) as a member of the Individual Health Care Research Group (IHC).

 

Prof. Gil’s research is focused on malaria and he has been lecturing and researching at the Karolinska Institutet, Stockholm, Sweden.

 

  1. Marcelo U. Ferreira, Tais Nobrega de Sousa, Gabriel W. Rangel, Igor C. Johansen, Rodrigo M. Corder, Simone Ladeia-Andrade, José Pedro Gil, Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions, International Journal for Parasitology: Drugs and Drug Resistance, Volume 15, 2021, Pages 9-24, ISSN 2211-3207,
    https://doi.org/10.1016/j.ijpddr.2020.12.001
  2. Calçada C, Silva M, Baptista V, Thathy V, Silva-Pedrosa R, Granja D, Ferreira PE, Gil JP, Fidock DA, Veiga MI. 2020. Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in Southeast Asia with increased substrate transport. mBio 11:e02093-20. https://doi.org/10.1128/mBio.02093-20
  3. Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, Gil JP. Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment. Pharmgenomics Pers Med. 2020;13:571-575
    https://doi.org/10.2147/PGPM.S276215
  4. Eva Peñas-LLedó, Enrique Terán, Marta Sosa-Macías, Carlos Galaviz-Hernández, Jose-Pedro Gil, Sujit Nair, Shyam Diwakar, Isabel Hernández, Julio Lara-Riegos, Ronald Ramírez-Roa, Ignacio Verde, Eduardo Tarazona-Santos, Juan Molina-Guarneros, Graciela Moya, Lembit Rägo, Adrián LLerena, Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting, Clinical Therapeutics, Volume 42, Issue 8, 2020, Pages 1595-1610.e5, ISSN 0149-2918,
    https://doi.org/10.1016/j.clinthera.2020.06.008
  5. Aminatou Kone, Sekou Sissoko, Bakary Fofana, Cheick O. Sangare, Demba Dembele, Aboubecrine Sedhigh Haidara, Nouhoum Diallo, Aoua Coulibaly, Aliou Traore, Sekou Toure, Kadidia Haidara, Kassim Sanogo, Issaka Sagara, Khalid B. Beshir, José P. Gil, Ogobara K. Doumbo, Abdoulaye A. Djimde, Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy, International Journal of Infectious Diseases, Volume 95, 2020, Pages 399-405, ISSN 1201-9712,
    https://doi.org/10.1016/j.ijid.2020.03.082

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.